Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This study will further characterize the activity of Tositumomab and Iodine I 131-Tositumomab in patients with relapsed indolent non-Hodgkin\'s Lymphoma who have progressed following treatment with rituximab.
Epistemonikos ID: 814e455719237fd65d43ca3ee6441daf52121d7f
First added on: May 04, 2024